Radiation Dosimetry Study of [89Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography

Development of a Novel Long-Lived ImmunoPET Tracer for Monitoring Lymphoma Therapy in a Humanized Transgenic Mouse Model

(2012) Arutselvan Natarajan et al.   BIOCONJUGATE CHEMISTRY

Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using 89Zr-ibritumomab tiuxetan and PET

(2012) Saiyada N. F. Rizvi et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Positron Emission Tomography of 64Cu-DOTA-Rituximab in a Transgenic Mouse Model Expressing Human CD20 for Clinical Translation to Image NHL

(2012) Arutselvan Natarajan et al.   MOLECULAR IMAGING AND BIOLOGY

RADAR Commentary: Evolution and Current Status of Dosimetry in Nuclear Medicine

(2011) M. G. Stabin et al.   JOURNAL OF NUCLEAR MEDICINE

RADAR Realistic Animal Model Series for Dose Assessment

(2010) M. A. Keenan et al.   JOURNAL OF NUCLEAR MEDICINE

ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies)

(2010) T. Olafsen et al.   PROTEIN ENGINEERING DESIGN & SELECTION

In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography

(2010) Ingo M Irmler et al.   ARTHRITIS RESEARCH & THERAPY

A recovery coefficient method for partial volume correction of PET images

(2009) Shyam M. Srinivas et al.   ANNALS OF NUCLEAR MEDICINE

Radioimmunoimaging with Longer-Lived Positron-Emitting Radionuclides: Potentials and Challenges

(2009) Tapan K. Nayak et al.   BIOCONJUGATE CHEMISTRY

MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- and 90Y-Ibritumomab Tiuxetan

(2009) D. R. Fisher et al.   JOURNAL OF NUCLEAR MEDICINE

Recombinant Anti-CD20 Antibody Fragments for Small-Animal PET Imaging of B-Cell Lymphomas

(2009) T. Olafsen et al.   JOURNAL OF NUCLEAR MEDICINE

The Role of Complement in the Mechanism of Action of Rituximab for B-Cell Lymphoma: Implications for Therapy

(2008) X. Zhou et al.   ONCOLOGIST